Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2542079 Title: BEHANDLUNG RHEUMATOIDER ARTHRITIS MIT EINER KOMBINATION AUS LAQUINIMOD UND METHOTREXAT

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
117513002
WO application number:
US2011026885
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2542079
WO publication number:
WO 2011/109531
1rst applicant's nationality:
Translation language:
German
EPO publication language:
English
SPC number:

Dates

Filing date:
02/03/2011
Grant date:
21/05/2014
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
12/08/2014
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
21/05/2014
EP B1 publication date:
21/05/2014
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/03/2015
Expiration date (if granted and all annual fees paid):
02/03/2031

Applicant

Name:
Teva Pharmaceutical Industries Ltd.
Legal Form:
From:
21/05/2014
Address:
5 Basel Street P.O. Box 3190, 49131 Petach-Tikva, Israel (IL)
To:

Agent

1

Name:
GEVERS PATENTS
Legal Form:
From:
08/02/2024
Address:
De Kleetlaan 7A, 1831, DIEGEM, Belgium (BE)
To:

2

Name:
GEVERS PATENTS
Legal Form:
From:
15/12/2017
Address:
Holidaystraat 5, 1831, DIEGEM, Belgium (BE)
To:
08/02/2024

3

Name:
COULON Ludivine
Legal Form:
From:
27/11/2014
Address:
Holidaystraat 5, 1831, DIEGEM, Belgium (BE)
To:
15/12/2017

Inventor

1

Name:
BLAUGRUND, Eran
Legal Form:
Address:

2

Name:
TARCIC, Nora
Legal Form:
Address:

3

Name:
KAYE, Joel
Legal Form:
Address:

Priority

Priority patent number:
339375
Priority date:
03/03/2010
Priority country:
United States (US)

Classification

Main IPC class:
A61K 31/4704;
IPC or IDT classification:
A61K 31/519; A61P 19/02;

Publication

Bulletin

1

Bulletin heading:
EP3
Journal edition number:
2014/08
Publication date:
16/09/2019
Description:
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws

2

Bulletin heading:
VRV
Journal edition number:
2015/09
Publication date:
16/09/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
12/08/2014 Translations 32 PDF /9/7/0/2/4/0612542079/docs/117513002_0_translations_20141121_110633194.pdf
08/02/2024 Request For Change Letter and/or Form requesting a change in the Register 2 PDF /9/7/0/2/4/0612542079/docs/117513002_1_rfc_20240307_112126590.pdf